Literature DB >> 21490877

MR Spectroscopy in the diagnosis and treatment of breast cancer.

Michael T Nelson1, Lenore I Everson, Michael Garwood, Tim Emory, Patrick J Bolan.   

Abstract

In vivo proton magnetic resonance spectroscopy ((1)H MRS) is rapidly becoming useful as a clinical tool for diagnosing and characterizing breast cancers. Alterations of the levels of choline-containing metabolites are associated with malignancy. High-field MR scanners at 1.5 T, 3 T, 4 T, and 7 T have been used to evaluate the role of (1)H MRS measurements of total choline containing compounds in patients with breast cancer. This article will review clinical use of MRI/MRS in vivo. Newer developments in high field MR scanning and quantitative MRS may help breast imagers improve sensitivity and specificity in diagnosing and treating breast cancer.

Entities:  

Year:  2008        PMID： 21490877      PMCID： PMC3073311          DOI： 10.1053/j.sembd.2008.03.004

Source DB:  PubMed          Journal:  Semin Breast Dis        ISSN： 1092-4450


  31 in total

1.  Automatic quantitation of localized in vivo 1H spectra with LCModel.

Authors:  S W Provencher
Journal:  NMR Biomed       Date:  2001-06       Impact factor: 4.044

2.  Overexpression of phospholipase D1 in human breast cancer tissues.

Authors:  D Y Noh; S J Ahn; R A Lee; I A Park; J H Kim; P G Suh; S H Ryu; K H Lee; J S Han
Journal:  Cancer Lett       Date:  2000-12-20       Impact factor: 8.679

3.  Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells.

Authors:  E O Aboagye; Z M Bhujwalla
Journal:  Cancer Res       Date:  1999-01-01       Impact factor: 12.701

4.  Adding in vivo quantitative 1H MR spectroscopy to improve diagnostic accuracy of breast MR imaging: preliminary results of observer performance study at 4.0 T.

Authors:  Sina Meisamy; Patrick J Bolan; Eva H Baker; Matthew G Pollema; Chap T Le; Frederick Kelcz; Mary C Lechner; Barbara A Luikens; Richard A Carlson; Kathy R Brandt; Kimberly K Amrami; Michael T Nelson; Lenore I Everson; Tim H Emory; Todd M Tuttle; Douglas Yee; Michael Garwood
Journal:  Radiology       Date:  2005-08       Impact factor: 11.105

5.  Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy.

Authors:  K A Kvistad; I J Bakken; I S Gribbestad; B Ehrnholm; S Lundgren; H E Fjøsne; O Haraldseth
Journal:  J Magn Reson Imaging       Date:  1999-08       Impact factor: 4.813

6.  Motion correction and lipid suppression for 1H magnetic resonance spectroscopy.

Authors:  J M Star-Lack; E Adalsteinsson; G E Gold; D M Ikeda; D M Spielman
Journal:  Magn Reson Med       Date:  2000-03       Impact factor: 4.668

7.  1H chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast.

Authors:  P E Sijens; M J van den Bent; P J Nowak; P van Dijk; M Oudkerk
Journal:  Magn Reson Med       Date:  1997-02       Impact factor: 4.668

8.  Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1)H MR spectroscopy--a pilot study at 4 T.

Authors:  Sina Meisamy; Patrick J Bolan; Eva H Baker; Robin L Bliss; Evin Gulbahce; Lenore I Everson; Michael T Nelson; Tim H Emory; Todd M Tuttle; Douglas Yee; Michael Garwood
Journal:  Radiology       Date:  2004-11       Impact factor: 11.105

9.  Resolution improvements in in vivo 1H NMR spectra with increased magnetic field strength.

Authors:  R Gruetter; S A Weisdorf; V Rajanayagan; M Terpstra; H Merkle; C L Truwit; M Garwood; S L Nyberg; K Uğurbil
Journal:  J Magn Reson       Date:  1998-11       Impact factor: 2.229

10.  Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1H MRS at 1.5 T.

Authors:  Peter Stanwell; Laurence Gluch; David Clark; Boguslaw Tomanek; Luke Baker; Bruno Giuffrè; Cynthia Lean; Peter Malycha; Carolyn Mountford
Journal:  Eur Radiol       Date:  2004-09-03       Impact factor: 5.315
View more
  3 in total

1.  Differential diagnosis between malignant and benign breast lesions using single-voxel proton MRS: a meta-analysis.

Authors:  Dongzhi Cen; Li Xu
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-06       Impact factor: 4.553

2.  CEST-MRI detects metabolite levels altered by breast cancer cell aggressiveness and chemotherapy response.

Authors:  Kannie W Y Chan; Lu Jiang; Menglin Cheng; Jannie P Wijnen; Guanshu Liu; Peng Huang; Peter C M van Zijl; Michael T McMahon; Kristine Glunde
Journal:  NMR Biomed       Date:  2016-04-21       Impact factor: 4.044

3.  Automated Acquisition Planning for Magnetic Resonance Spectroscopy in Brain Cancer.

Authors:  Patrick J Bolan; Francesca Branzoli; Anna Luisa Di Stefano; Lucia Nichelli; Romain Valabregue; Sara L Saunders; Mehmet Akçakaya; Marc Sanson; Stéphane Lehéricy; Małgorzata Marjańska
Journal:  Med Image Comput Comput Assist Interv       Date:  2020-09-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.